FREE CASE EVALUATION: +1 (415) 965 2258
Email us: contact@thejusticenow.com
The Justice Now is currently handling Cartiva Lawsuits on behalf of patients who have received Cartiva Big Toe Joint Implant \to treat arthritis. Cartiva implants may sink into the adjacent bone, causing implant failure, pain, and other injury to the patient.
Victims are now pursuing legal claims to receive fair compensation. Join today
If we Don’t Win Your Case, You Don’t Pay a Dime
We offer a Free Consultation for Your Case
Complete Form Below For Your Free Review
The most common arthritis of the foot is that which affects the base of the big toe, also known as hallux rigidus. Big toe arthritis is a painful condition that affects 1 in 40 people over the age of 50. Sometimes patients may opt for toe fusion surgery due to excruciating pain, but this fuses the joints into one large joint and limits mobility. The Cartiva big toe joint implant works as an alternative to toe fusion surgery and does not restrict movement in the joint. However, doctors and patients have reported that joint implants cause more toe problems and injuries. Contact us today to learn more about how a Cartiva joint implant trial can benefit you.
The Justice Now is currently handling lawsuits on behalf of patients who received Cartiva toe implants for the treatment of arthritis. Cartiva implants can sink into adjacent bone, causing implant failure, pain and patient injury.
Get Free Consultation from our expert lawyers, that can help you get compensation
Patients are given the Cartiva implant to treat arthritis of the big toe and relieve friction caused by worn cartilage. This device consists of a small cylindrical cap made of polyvinyl alcohol (PVA), which mimics natural cartilage. In a minimally invasive procedure, medical professionals insert a synthetic implant into the big toe joint through an opening at the end of the metatarsal bone. It acts like normal cartilage and allows the patient to move the joint freely, unlike toe fusion surgery. With Cartiva’s big toe joint implants, patients should be able to perform daily activities as painlessly as a normal toe joint. Before bringing it to market, researchers conducted extensive testing of the Cartiva implant to gain FDA approval. Initial studies showed that the device successfully treated arthritis, and patients reported relief and satisfaction with the results.
Wright Medical Group acquired Cartiva and its thick joint implant for $35 million in 2018, and its expected success matched positive clinical trials for the implant. However, reports quickly emerged that doctors were unable to replicate the effective results of previous studies. As a result, many doctors have grown weary of recommending or using the Cartiva implant. Surgeons have significantly reduced the demand for Cartiva implants due to the following complaints:-
Experts at the university’s Foot and Ankle Institute speculate that the failure of the Cartiva implants may be directly related to a faulty design mechanism that causes the implant to slip into the bone. An exceptionally smooth surface on an implant can cause malfunction, as many implants require irregularities in the surface material. In addition, the supporting bone may be too weak to provide adequate support for the implant. It is unclear how much force can be applied to the implant without interfering with its ability to function properly. Many surgeons have warned against Cartiva’s toe implant because the manufacturer has not addressed or corrected these defects. Hence, Cartiva Big-Toe Lawsuit Started.
Although the study results were positive, many doctors did not see the same results in their practice. The Cartiva implant is prone to failure, also known as subsidence, because it slides into the bone. After returning for follow-up visits, many surgeons reported that the implant had sunk into the patient’s bone. Patients reported a 6 percent failure rate, compared to 13.5 percent in manufacturers’ clinical trials. The high rate of device failure prompted surgeons to stop using Cartiva and warn patients about the potential for failure. The lawsuits allege that the companies were aware of serious malfunctions and risks, but misled the public about the effectiveness of the implants.
In October 2022, a Texan filed a product liability lawsuit against Cartiva Inc., Wright Medical Group and Stryker, manufacturers of big toe implants. Plaintiff Cathy Atkinson explains that she received a Cartiva SCI toe implant in November 2018. However, she claims the defective implant did not relieve her pain or restore her range of motion. In fact, Atkinson required expensive revision surgery to remove the implant and additional fusion surgery to correct the bone loss and deformity caused by the faulty big toe joint implant.
If you or a loved one experiences additional complications after receiving Cartiva implants, you can file a Cartiva implant lawsuit. The Justice Now can help you obtain compensation:
Manufacturers considered Cartiva’s big toe joint implant to be a better alternative to fusion surgery. Although patients hoped to receive arthritis relief while maintaining their mobility, the lawsuits allege that the Cartiva implant increased their pain and worsened their condition. The plaintiffs allege that faulty design and misleading claims led them to seek corrective surgery after receiving Cartiva implants. Having a second surgery can be a difficult and frustrating experience, especially after you believe an implant is providing much-needed relief. Consider hiring one of our experienced experts to improve your chances of success in your Cartiva big toe implant lawsuit.
The Justice Now, Is another name for the success in Personal Injury Lawsuit. Our dedicated team of attorneys is focused to seeking justice for those who have been injured or killed due to the negligence of others.
Our experienced attorneys handle a wide range of drug, medical device and other defective product cases. The attorneys at our firm have helped collect millions of dollars for our clients. The Justice Now will protect you and your rights. For a free confidential case evaluation, Please Fill the Form Given on this Page or Call at +1-888-885-2771 .
Get Free Consultation from our expert lawyers, that can help you get compensation
A1.The FDA has received a total of 144 adverse events involving the Cartiva since it was first approved. Almost all of these events involved the migration of the implant due to shrinkage. A post-market study found that patients with the Cartiva implant reported failure rates as high as 64%.
A2.Many failures of Cartiva toe implants have been reported by people who suffered injuries from the device loosening and sliding into the bone. Individuals are now filing lawsuits against Cartiva, alleging that the toe implant was improperly designed, leading to a high risk of failure and severe pain.
A3. The device is sliding. Increased pain. Reduced range of motion. Sinking (the implant slides into the bone)
A4. Statistics on complications from central venous cath are shocking. Around one-third of patients experience some complication. The most common is infection. The majority of these complications are easy to treat. When a defective product is the cause of the injury, the results are usually more severe.
Defective medical devices can degrade and cause fractures and breaks, which may lead to infections, sepsis, organ damage, blood clots, and strokes.
A5. How successful is Cartiva’s operation? Cartiva-sponsored clinical trials claimed an 87% success rate for Cartiva big toe implant surgery. However, recent independent studies have shown that the success rate of Cartiva implant surgery is significantly lower than advertised, anywhere from 6 to 21 percent.
A6. You can return to most activities after 6 weeks. The swelling often lasts for 6 months. You are expected to make a FULL recovery (no pain, swelling, ability to walk, etc.) within 6 months.
A7. If it doen’t create problem like it is doing right now – Lifelong. You can also remove or replace the Cartiva implant at any time without complications.
A8. Cartilage regeneration usually requires some sort of surgical procedure. Synthetic additives are often required to successfully regenerate articular cartilage. Adults lack the natural ability to grow new joint cartilage from scratch. This ability is only possible for a fetus growing in the womb.
A9. The wound will heal within 2- 4 weeks after surgery, and during this time, limited activity, including rest, is recommended. The dressings will be removed and replaced after a week, allowing you to see your progress and discuss it with Dr Pocklington. The stitches are usually removed after 2 weeks.
A10. The procedure is 40% Faster than fusion surgery, and recovery is faster even without casts and crutches, and patients are usually able to bear weight on their big toe immediately after surgery. Optimal recovery can take 6-12 months.
A11. First, remove the Cartiva implant from the metatarsal bone by placing a K-wire in the center of the implant to facilitate removal. Next, drill with an appropriately sized cannulated reamer at least 1 mm larger than the removed Cartiva implant, as well as a bone pin of appropriate diameter.
A12. CARTIVA is implanted using special instruments designed to allow the surgeon to obtain an implant that fits well with a compression implant. According to the size of the device to be implanted (6 mm, 8 mm, 10 mm and 12 mm). Guide wire 2.0 mm unthreaded. Press CARTIVA before implantation.
